Neko Health Hits $1.8B Valuation with $260M Series B
- Neko Health has secured $260m in Series B funding, valuing the company at $1.8 billion.
- Neko plans to expand into the U.S. market, enhance diagnostics, and open more clinics.
- Demand for Neko's health services is soaring, with a waitlist surpassing 100,000 people globally.
- Lightspeed Venture Partners led the round.
- Neko Health uses advanced tech for data-driven diagnostics and consultations.
- The funding will drive R&D efforts to advance medical hardware and software capabilities annually, enhancing service offerings.
Source: TechCrunch
B.O